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Abstract 
Objective: As part of a larger study to understand how Envelope N-glycosylation influences HIV-1 pathogenesis, we 
selected a participant infected with a single Subtype C variant and determined whether deletion of specific potential 
N-glycan sites (PNGs) impacted Envelope function longitudinally.
Results: We deleted five PNGs previously linked to HIV-1 transmission of two matched Envelope clones representing 
variants at 5 and 173 weeks post-infection. The transmitted founder (TF) had significantly better pseudovirus entry 
efficiency than the chronic infection (CI) variant. Deletion of all PNGs significantly reduced TF entry efficiency, bind-
ing to dendritic cell-specific intracellular adhesion molecule 3 grabbing non-integrin (DC-SIGN) receptor and trans-
infection. However, mutational analysis did not affect the phenotype of the CI Envelope to the same extent. Notably, 
deletion of the PNGs at N241 and N448 had no effect on CI Envelope function, suggesting that some PNGs might 
only be important during acute infection. Therefore, vaccines that elicit antibodies against N-glycans important for 
TF Envelope function could drive the loss of PNGs during immune escape, abrogating viral replication. Conversely, 
changes in N-glycosylation might have no effect on some variants, reducing vaccine efficacy. This finding highlights 
the need for further investigation into the role of Envelope N-glycosylation in HIV-1 pathogenesis.
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Introduction
Previous reports suggested that Envelope (Env) N-gly-
cosylation is essential for HIV-1 transmission [1–4] and 
N-glycosylation patterns differ between transmitted 
founder (TF) and chronic infection (CI) variants [5]. Sev-
eral different mechanisms have been suggested to explain 
the influence of Env N-glycosylation on the transmis-
sion of R5 tropic variants such as sensitivity to immune 
responses and enhanced binding to dendritic cell-specific 
intracellular adhesion molecule 3 grabbing non-integrin 
(DC-SIGN) and alpha4beta7 receptors via Env N-glycans 
[6–8]. Go et  al. [5] found that TF Env was more heav-
ily mannosylated than CI clones, markedly at conserved 
PNG sites N241, N262, N386, N392 and N448, suggest-
ing that these sites might play a different role in Env 
function during acute infection than during the chronic 
stage. As part of a larger study focussed on the role of 
Env N-glycosylation in HIV-1 subtype C pathogenesis, 
we determined whether the loss of these PNGs impacted 
Env function differently over the course of infection.
As dendritic cells (DCs) are found within the female 
genital tract (FGT), express DC-SIGN that bind gp120 
high mannose N-glycans and facilitate trans-infection 
of CD4 T cells in the lymph nodes [9, 10], we tested 
whether matched TF and CI variants from a subtype C 
single variant transmitted participant differed in man-
nosylation, binding to DC-SIGN and trans-infection. We 
hypothesised that if TF Envs were enriched with high 
mannose compared to CI variants then they would bind 
DC-SIGN with high affinity resulting in enhanced  CD4+ 
T cell trans-infection [11]. When there was no clear 
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relationship between Env N-glycosylation and DC-SIGN 
binding, we deleted PNGs at N241, N262, N386, N392 
and N448 and determined Env function as these sites not 
only carried high mannose residues but N386 and N392 





Two full-length envelopes (env) were cloned from an HIV 
positive woman sampled at 5 and 173 weeks post-infec-
tion (wpi) from a larger cohort described in Abrahams 
et  al. [14]. The original study obtained ethical approval 
from institutional review boards, and all participants 
provided written informed consent [5]. The two func-
tional Env clones (TF and CI) were generated from sin-
gle-genome-amplification (SGA)—derived PCR products 
and cloned into pcDNA/His-Topo (Invitrogen). [Acces-
sion numbers: FJ443350.1 and HQ625601 (https ://www.
ncbi.nlm.nih.gov)]. Sequences were aligned in Bio-edit.
Cell culture
Human embryonic kidney (HEK) 293 T cells (Gift from 
Carolyn Williamson, Institute of Infectious Diseases and 
Molecular Medicine, University of Cape Town & NHLS) 
and TZM-bl cells [NIH AIDS Reagent Program (ARP), 
Division of AIDS, NIAID from Dr. John C. Kappes, Dr. 
Xiaoyun Wu and Tranzyme Inc] were maintained in Dul-
becco modified Eagle high glucose medium (DMEM) 
(Lonza, Whitehead Scientific) supplemented with 10% 
fetal bovine serum (FBS) (PAA, Biocom Biotech), 1  U/
mL penicillin and 1 µg/mL streptomycin (Lonza, White-
head Scientific). Raji cells [NIH-ARP from Alexandre 
Kabamba at the National Institute of Communicable 
disease (NICD), South Africa] and Raji DC-SIGN cells 
(NIH-ARP, from Drs. Li Wu and Vineet N. KewalRam-
ani) were maintained in RPMI supplemented with 10% 
FBS. All cells were grown in a humidified incubator at 
37 °C with 5%  CO2.
Generation of mutants
Modified Quikchange® site directed mutagenesis (Strat-
agene) was used to delete PNGs and insert stop codons 
in gp160. Complimentary primers carrying the desired 
mutations and silent restriction enzymes sites were 
used to amplify env with the following cycling condi-
tions: 94  °C for 3  min followed by 20 cycles of 94  °C 
for 30  s, 55  °C or 58  °C for 30  s, 72  °C for 12  min and 
a final annealing step at 72 °C for 20 min using Phusion 
Hotstart (Thermo Scientific, USA). SDM PCR products 
were digested with DpnI (Thermo Scientific®, USA) 
before competent E.coli (Promega) were transformed. 
Plasmid was extracted using the PureYield™ Plasmid 
Miniprep System (Promega) according to the manu-
facturer’s instructions. Mutations were confirmed by 
sequencing (CAF Stellenbosch, SA).
N‑glycosylation analysis of Env
To express gp140, 4 × 105 HEK 293  T cells were trans-
fected with 6  µg of each env clone using PEI (Polyeth-
yleneimine) (Sigma-Aldrich, USA). After transfection, 
HEK 293  T cell culture medium was diluted 1:1 with 
1  mL of binding buffer (20  mM morpholineethanesul-
fonic acid, 130 mM NaCl, 10 mM  CaCl2) at 4   C before 
the addition of 20  µL Galanthus nivalis agarose beads 
(Sigma-Aldrich®). Binding was carried out overnight at 
4  C and the beads were washed twice with PBS (White-
head Scientific) and then treated with either endo-β-N-
acetylglucosaminidase H (EndoH) (0.5 U) or peptide 
N-glycosidase F (PNGaseF) (0.5 U) according to the man-
ufacturers recommendations (New England Biolabs®) 
and then analysed by SDS-PAGE and Western blotting. 
Differences in N-glycosylation were determined by com-
paring the molecular weight (MW) of N-glycosylated 
(untreated), demannosylated (EndoH-treated) and fully 
deglycosylated gp140 (PNGaseF-treated) and the level of 
high mannose N-glycans was calculated as a percentage of 
total N-glycans using the formula: [(Untreated − EndoH-
treated)/(Untreated) − (PNGaseF-treated)] × 100.
Pseudovirus production
HEK 293  T cells were transfected with 2.5  µg of gp160 
and 5  µg of the viral backbone (pSG3ΔEnv). Culture 
medium was collected 48 h following transfection and fil-
tered through a 0.22 µm pore size filter, FBS was adjusted 
to 20% and PSV was stored in single-use aliquots at 
− 70 °C.
p24 ELISA
A chemiluminescent p24 ELISA (Aalto Bio-reagents) 
and the  TROPIX® detection system (CDP-Star®, Applied 
Biosystems) was used to determine the concentration of 
PSV. Relative light units (RLU) were converted to p24 
concentration (ng/mL) using a standard curve and non-
linear regression analysis.
Pseudovirus entry assay
TZM-bl cells were seeded at  104 cells per well before 
infection with fivefold serial dilutions of PSV for 48 h at 
37 °C. All PSV were normalised to 100 ng/mL p24 prior 
to serial dilution and infectivity was measured by lumi-
nescence using BriteGlo® (Promega) and luminometer 
(Turner Biosystems®). Negative controls included back-
ground luminescence of wells carrying cells only or cells 
transfected with pSG3ΔEnv only.
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DC‑SIGN binding assay
Ten ng/mL p24 pseudovirus was added to Raji and Raji 
DC-SIGN cells at a density of  105 cells/well in a total 
volume of 200 µL. After binding for 2.5 h at 37 °C, cells 
were washed four times by centrifugation (2500  rpm) 
with RPMI to remove all unbound virus, then lysed in 
1% Empigen-TBS before determining cell-associated p24 
(Aalto Biosystems).
Generation of monocyte derived dendritic cells (MDDCs)
PBMCs were obtained from healthy blood donor buffy 
coats by density gradient centrifugation using Ficoll-
Hypaque (Sigma-Aldrich). Monocytes were isolated from 
PBMCs by positive selection using CD14+ coated beads 
(130-050-201 Miltenyi, USA or Biochom Biotech, SA) 
according to manufacturer’s instructions or by adher-
ence. Monocytes were adhered in serum-free medium for 
two hours at 37  °C, 5%  CO2, non-adherent cells washed 
and differentiated in medium with 1000 U/mL GM-
CSF (PHC2013, Biosource), and 500 U/mL of recombi-
nant human IL-4 (PHC0045, Biosource) for 6 days with 
recombinant cytokines supplemented every other day.
Trans‑infection
PSV was normalised using p24 ELISA and equal quan-
tities of virus was used to infect TZM-bl cells directly 
and indirectly via binding first to Raji DC-SIGN cells 
and MDDCs. PSV was bound to  105 Raji DC-SIGN cells 
or MDDCs and unbound virus was removed by wash-
ing with RPMI before adding to TZM-bl cells seeded 
at a density of  104 cells/well. Cells were incubated at 
37  °C with 5%  CO2 for 48 h and pseudovirus entry was 
measured using BriteGlo® (Promega) and luminometer 
(Turner Biosystems® Modulus Microplate).
Results and discussion
A CAPRISA 002 study participant, CAP239, was shown 
to be infected with a single variant at transmission 
through sequencing twenty SGA env PCR products at 
5 wpi [14]. Two Envs were cloned at 5 and 173 wpi and 
selected for mutational analysis as they both carried 
N241, N262, N386, N392 and N448, unlike other clones 
(Fig.  1a), and these were compared for Env expression 
and mannosylation as well as PSV entry efficiency, DC-
SIGN binding and trans-infection of CD4+ cells.
We first confirmed the expression of Env in the 
absence and presence of the PSV backbone, pSG3Δenv. 
Although expression increased with the co-transfection 
of pSG3Δenv, there was no difference between TF and CI 
Env expression (Fig. 1b). The CI clone had a higher MW 
than the TF and showed a clear gp120 band that was not 
apparent for the TF. However, when Env was digested 
with PNGaseF, a band corresponding to deglycosylated 
gp120 was observed (data not shown), indicating that 
TF Env was cleaved, albeit less efficiently than the CI 
clone. The higher apparent MW of CI Env is likely due to 
N-glycosylation as the predicted MW of the two clones 
differed by only 1 KDa. Although the Envs shared 20 con-
served PNGS, seven PNGS were gained and five PNGS 
were lost so that the CI Env carried two additional PNGs 
(Fig.  1a). Envs were mutated to delete the transmem-
brane domain of gp41 to generate soluble gp140 con-
structs. When soluble gp140 was digested with EndoH 
and PNGaseF which demannosylate and deglycosylate, 
respectively, shifts in MW indicated that gp140 of the TF 
was more heavily mannosylated (45% vs 34%), suggesting 
that the CI clone carried more complex-type N-glycans 
(Fig. 1c). It is possible that the number of complex N-gly-
cans, with negatively charged sialic acid moieties, led to 
more extensive smearing of CI gp160 during SDS PAGE, 
distorting its MW.
Changes in N-glycosylation have been shown to influ-
ence Env function [8]. When PSV was used to infect 
TZM-bl cells, the TF Env had threefold higher entry effi-
ciency than the matched CI variant (Fig. 1d). This find-
ing was supported by an earlier study that showed that 
infectious molecular clones (IMCs) carrying TF Envs 
from subtype C and subtype B HIV had twofold higher 
replication capacity than unmatched CI Envs [11]. Next, 
PSV, with known entry efficiency, was bound to either 
Raji DC-SIGN or monocyte derived dendritic cells 
(MDDCs) before adding to TZM-bl cells. The CI PSV 
was transferred significantly better to TZM-bl cells than 
TF by Raji-DC-SIGN cells (Fig.  1f ). On the contrary, 
MDDCs apparently transferred TF PSVs better than CI 
virus (Fig. 1g). There was no difference in DC-SIGN bind-
ing between TF and CI PSVs (Fig.  1e), suggesting that 
MDDC-mediated trans-infection might be influenced by 
receptors other than DC-SIGN. Therefore, the only con-
sistent significant difference between TF and CI Env phe-
notype was the ability to mediate entry of CD4+ TZM-bl 
cells.
The PNGs at positions 241, 262, 448, 386, and 392 
were conserved across TF and CI Env sequences. To 
determine whether loss of mannose N-glycans and/
or disruption of the potential DC-SIGN binding site 
affected Env function, the PNGs were deleted singly 
and in combination. Our data supports previous find-
ings that showed N262 was important for Env function 
[15, 16]. However, PNG deletion affected the func-
tion of the Env clones differently: N392Q abrogated 
the function of CI Env but only reduced the entry effi-
ciency of the TF clone, albeit significantly. Overall, TF 
Env was highly sensitive to N-glycan deletion as PSV 
entry efficiency, DC-SIGN binding and trans-infection 
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of all mutants were significantly reduced compared to 
wild-type (WT) (Fig. 1h). On the contrary, CI Env was 
not affected to the same extent as deletion of PNGs at 
N241 and N448 had no significant effect on its function 
(Fig. 1i). Deletion of N448 seemed to increase the entry 
efficiency of C16 supporting a previous report that 
Fig. 1 Phenotypic comparison of transmitted founder and matched chronic infection Envelopes. Env sampled from a participant at 5 (transmitted 
founder; TF) and 173 (chronic infection; CI) weeks post-infection were expressed in HEK293T cells. a The sequences of the two clones (C15 and 
C16) were aligned in Bioedit and PNGs are indicated with asterisk. Gp120 sequence is shown starting from the first potential N-glycan site (PNG) 
at position 88 (HXB2 numbering) with variable loops indicated. b Env expression was determined in the presence and absence of pSG3Δenv by 
Western blotting. β-actin, a protein loading control, gp160 and gp120 are indicated with arrows. A representative of three independent experiments 
is shown. c Gp140 was digested with EndoH and PNGaseF and the molecular weight (MW) was compared to that of undigested gp140 using 
Western blotting. Mannosylation (%) was determined using the equation: [(Untreated – EndoH-treated)/(Untreated) − (PNGaseF-treated)] × 100. 
The average of two biological repeats with standard error of the mean (SEM) are indicated. Statistical analysis was done using One-way Anova. 
Pseudovirus (PSV) was compared for their ability to d infect TZM-bl cells, e bind to Raji-DC-SIGN cells and trans-infect TZM-bl cells after capture by 
f Raji-DC-SIGN or g MDDCs. The average relative light units (RLU) of four independent entry efficiency experiments are indicated. DC-SIGN binding 
of three independent experiments was calculated relative to PSV input (%) and trans-infection of four biological experiments are indicated relative 
to the entry efficiency of equivalent PSV (%). Error bars represent SEM and statistical analysis was done using Mann Whitney U test. h TF and i CI Env 
potential N-glycan sites (PNGs) at N241, N262, N448, N386 and N392 (HXB2 numbering) were deleted by site-directed mutagenesis and compared 
to WT for their ability to infect TZM-bl cells, bind to DC-SIGN, and trans-infect TZM-bl cells. Bars indicate the mean of two independent experiments 
with SEM. Statistical analysis was done using One-way Anova and Bonferroni’s post-test. PSVs generated using pSG3∆Env and empty vector was 
used as a negative control (Ctrl). For all statistical analysis, *, ** and *** indicate p values < 0.05, p < 0.01 and p < 0.001, respectively relative to WT, ns 
was not significant
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suggested loss of the N-glycan at this position affected 
the structure of the C4 region although this effect 
was not apparent for C15 [17]. Therefore, the overall 
N-glycan arrangement of CI Env might be able to com-
pensate for the fitness cost associated with the loss of 
N241 and N448. On the contrary, the structure of TF 
Env seemed less able to accommodate the loss of any of 
the five PNGs, suggesting that these sites are important 
for Env entry efficiency during acute infection. When 
we compared the sequences of 589 Subtype C Env 
sequences (https ://www.lanl.com), all five PNGs were 
conserved, supporting the suggestion that these sites 
play a very important role in Env function. However, 
it seems as though Env structure and function become 
less reliant on these PNGs during disease progression 
probably to accommodate immune escape mutations 
via the shifting glycan shield. C15 and C16 differed by 
43 amino acids with the most marked difference within 
V1 that resulted in the introduction of 3 PNGs (Fig. 1a). 
Despite the five PNGs becoming less important for Env 
function over time, they are highly conserved across 
variants from chronic infection, suggesting that they 
might be important for alternative processes. Overall, 
the data suggests that the role of N-glycans in the main-
tenance of Env structure and function varies accord-
ing to time post infection. This begs the question: how 
quickly do some N-glycans become obsolete? This has 
important ramifications for the design of vaccines that 
include N-glycan epitopes, as the loss or gain of PNGs 
associated with escape from neutralizing immune 
responses might drive changes in viral fitness that differ 
according to the HIV infected participant.
Limitations
The limitation of the study is the small sample size.
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